ROBERT ANG - 06 May 2025 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Katie Kazem, Attorney-in-Fact
Issuer symbol
VOR
Transactions as of
06 May 2025
Net transactions value
-$1,322
Form type
4
Filing time
07 May 2025, 16:05:57 UTC
Previous filing
02 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ANG ROBERT PRESIDENT AND CEO, Director C/O VOR BIOPHARMA INC., 100 CAMBRIDGEPARK DRIVE, SUITE 101, CAMBRIDGE /s/ Katie Kazem, Attorney-in-Fact 07 May 2025 0001741283

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VOR Common Stock Tax liability $1,322 -2,361 -0.26% $0.5600 911,318 06 May 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units.